Completado

Evaluation of Patients With Known or Suspected Heart Disease

0 criterios cumplidosConsulta de un vistazo cómo tu perfil cumple con cada criterio de elegibilidad.
Qué se está recopilando

Recolección de datos

Quiénes están siendo reclutados

Peripheral Artery Disease
+4

+ Coronary Disease
+ Diabetes and Heart Failure
Cómo está diseñado el estudio

Other

Observacional
Inicio del estudio: mayo de 1992

Resumen

Patrocinador PrincipalNational Heart, Lung, and Blood Institute (NHLBI)
Última actualización: 2 de julio de 2017
Extraido de una base de datos validada por el gobierno.Reclamar como socio
Fecha de inicio: 10 de mayo de 1992Fecha en la que se inscribió al primer participante.

In this study researchers will admit and evaluate patients with known or suspected heart disease referred to the Cardiology Branch of the National Heart, Lung, and Blood Institute (NHLBI). Patients participating in this study will undergo a general medical evaluation, including blood tests, urine, examination, chest x-ray and electrocardiogram (EKG). In addition, patients may be asked to have an echocardiogram (ultrasound scan of the heart) and to perform an exercise stress test. These tests are designed to assess the types and causes of patient's heart diseases and to determine if they can participate in other, specific research studies. The principal mission of the NIH is the conduct of research that elucidates biological mechanisms, pathogenesis, and treatment of disease. Patients with known or suspected cardiovascular diseases are referred to NHLBI cardiologists for consideration of participation in clinical research protocols. However, eligibility for participation is often uncertain from referral information or even after an outpatient evaluation. The purpose of this protocol is to permit inpatient evaluation of patients for whom participation in clinical research protocols is under consideration in order to determine protocol eligibility by means of conventional laboratory and cardiovascular testing.

Título OficialEvaluation of Patients With Known or Suspected Heart Disease (Screening Protocol) 
Patrocinador PrincipalNational Heart, Lung, and Blood Institute (NHLBI)
Última actualización: 2 de julio de 2017
Extraido de una base de datos validada por el gobierno.Reclamar como socio

Protocolo

Esta sección proporciona detalles del plan del estudio, incluyendo cómo está diseñado y qué se está evaluando.
Detalles del Diseño

Elegibilidad

Los investigadores buscan pacientes que cumplan ciertos criterios, conocidos como criterios de elegibilidad: estado general de salud o tratamientos previos.
Condiciones
Criterios
Cualquier sexoSexo biológico de los participantes elegibles para inscribirse.
Voluntarios sanos no permitidosIndica si personas sanas, sin la condición que se estudia, pueden participar.
Condiciones
Patología
Peripheral Artery Disease
Coronary Disease
Diabetes and Heart Failure
Dilated Cardiomyopathy
Heart Failure
Renal Artery Stenosis
Pulmonary Hypertension
Criterios

* INCLUSION CRITERIA: The following is a representative list of the types of patient presentations and potential diagnoses eligible for this protocol: 1. Coronary artery disease with angina or inducible myocardial ischemia as determined by noninvasive testing. 2. Cardiomyopathies including congestive phenotypes. 3. Peripheral artery disease with intermittent claudication or limb-threatening ischemia. 4. Renovascular disease with uncontrolled hypertension, intermittent pulmonary edema, or evidence of ischemic nephropathy. 5. Upper extremity peripheral artery disease. 6. Diabetes with heart failure. 7. Pulmonary hypertension. EXCLUSION CRITERIA: Pregnancy, for those patients who require catheterization-based diagnostics. Inability to provide informed consent.



Centros del Estudio

Estos son los hospitales, clínicas o centros de investigación donde se lleva a cabo el estudio. Puedes encontrar la ubicación más cercana a ti y su estado de reclutamiento.
Este estudio tiene 2 ubicaciones
Suspendido
Suburban HospitalBethesda, United StatesVer ubicación
Suspendido
National Institutes of Health Clinical Center, 9000 Rockville PikeBethesda, United States

Completado2 Centros de Estudio